Mar 2, 2026 08:01AM
Dec 18, 2025 08:05AM
Oct 16, 2025 08:05AM
Aug 6, 2025 08:05AM
May 15, 2025 08:06AM
May 15, 2025 08:05AM
Mar 21, 2025 08:05AM Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets
Nov 13, 2024 09:01AM
Nov 13, 2024 09:00AM
Nov 8, 2024 10:26AM
Aug 13, 2024 09:05AM
May 15, 2024 09:29AM
May 15, 2024 09:28AM
May 10, 2024 08:05AM Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update
Mar 28, 2024 09:05AM
Jan 8, 2024 09:04AM
Jan 8, 2024 09:00AM
Nov 9, 2023 09:05AM
Sep 19, 2023 09:05AM
Sep 19, 2023 09:05AM
Jul 11, 2023 09:06AM Pulmatrix (PULM) Submits IND Application to FDA to Initiate a Phase 2 Trial of PUR3100
Jul 11, 2023 09:05AM
Jun 15, 2023 09:20AM
Jan 4, 2023 09:05AM
Jan 4, 2023 09:05AM
May 12, 2022 09:10AM
May 12, 2022 09:05AM
Mar 29, 2022 09:05AM Pulmatrix Announces Year-End and Q4 Financial 2021 Results and Provides Corporate Update
Feb 1, 2022 09:01AM
Feb 1, 2022 09:00AM
Nov 10, 2021 04:15PM
Nov 9, 2021 09:01AM
Nov 9, 2021 09:00AM
May 11, 2021 04:35PM
Mar 23, 2021 09:05AM Pulmatrix Reports 2020 Financial Results and Provides Business Update
Mar 4, 2021 09:15AM
Mar 4, 2021 09:15AM
Nov 12, 2020 09:00AM
Sep 22, 2020 08:30AM
May 14, 2020 09:00AM
Mar 26, 2020 09:00AM
Jan 30, 2020 08:07AM Pulmatrix (PULM) Receives Fast Track Designation for Pulmazole for the Treatment of Asthma-ABPA
Jan 30, 2020 08:00AM
Jan 2, 2020 09:25AM
Nov 4, 2019 09:15AM
May 15, 2019 09:00AM
Apr 1, 2019 09:00AM
Feb 7, 2019 09:07AM
Feb 7, 2019 09:00AM Pulmatrix Receives IND Approval for Pulmazole Phase 2 Clinical Study
Nov 9, 2017 04:30PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All